Safety of Antithrombotic Heparin Proteoglycan Mimetic APAC in Peripheral Arterial Occlusive Disease and Chronic Limb-threatening Ischemia

Abroad (travel likely)RecruitingPHASE2

Conditions

Peripheral Arterial Occlusive Disease · Chronic Limb-Threatening Ischemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Helsinki University Hospital, Helsinki, Finland
Contact: Study coordinator (Maarit Venermo) · maarit.venermo@hus.fi · +358 9 4711
Tampere University Hospital, Tampere, Finland
Contact: Study coordinator (Eva Saarinen) · eva.saarinen@pirha.fi · +358 3 311 611
Turku University Hospital, Turku, Finland
Contact: Study coordinator (Harri Hakovirta) · harri.hakovirta@varha.fi · +358 2 313 0000

Study leads

Jarna Hannukainen
Study Director
Aplagon Oy

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study

Chronic Limb-Threatening Ischemia

Abroad (travel likely)Recruiting

Eisenstadt, Austria · Graz, Austria

SELUTION4BTK Trial

Peripheral Arterial Disease · Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities

Abroad (travel likely)Recruiting

Chandler, United States · Jonesboro, United States

Pressure Wire Guidance for Infrapopliteal Artery Interventions

Chronic Limb-Threatening Ischemia

Abroad (travel likely)Recruiting

Seoul, South Korea